Company news
Inmode Ltd. (NASDAQ:INMD) news
Inmode Ltd. news releases on 6ix. Latest, Sep 9, 2026: InMode Advances RF Microneedling Comfort with the Launch of Morpheus8 Cool
Press releases & updates
InMode Advances RF Microneedling Comfort with the Launch of Morpheus8 Cool
September 9, 2026
InMode Reports Second Quarter 2026 Financial Results: Quarterly GAAP Revenues of $95.6 Million, Consistent with the Second Quarter of 2025
August 5, 2026
Steel Partners Urges InMode Shareholders to Vote AGAINST the Re-Election of Dr. Hadar Ron and AGAINST Extraordinary Special Committee Compensation at the July 30 Annual General Meeting
July 27, 2026
Steel Partners Holdings L.P. Issues Letter to InMode Ltd. Board of Directors Regarding the Company’s Persistent and Egregious Governance Failures
July 16, 2026
InMode to Report Second Quarter 2026 Financial Results on August 5, 2026, Expects Q2 Revenue Between $95.2M-$95.4M, Reiterates FY 2026 Revenue Guidance Between $365M-$375M
July 13, 2026
Steel Partners Offers to Acquire InMode for $16.75 Per Share in Cash
July 9, 2026
InMode Confirms Receipt of Unsolicited Proposal
June 24, 2026
InMode Appoints Dr. Shlomo Nass as Chairman of the Board and Moshik Itzkovich as Chief Financial Officer
May 20, 2026
InMode Reports First Quarter 2026 Financial Results: Quarterly GAAP Revenue of $82 Million, Represents 5% Year-Over-Year Increase
May 6, 2026
InMode to Report First Quarter 2026 Financial Results and Hold Conference Call on May 6, 2026, Expects Q1 Revenue Between $81.5M-$81.7M, Reiterates FY 2026 Revenue Guidance Between $365M-$375M
April 12, 2026
InMode to Present at the 25th Annual Needham Virtual Healthcare Conference
March 23, 2026
InMode Announces New Share Repurchase Program
March 12, 2026
InMode Announces Conclusion of Independent Transaction Committee Review
February 22, 2026
InMode Reports Fourth Quarter and Full Year 2025 Financial Results: Quarterly GAAP Revenue of $103.9 Million and Full Year Revenue of $370.5 Million
February 10, 2026
InMode to Participate in the 13th Annual BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference
February 2, 2026
InMode Responds to Transaction Rumors
February 1, 2026
InMode to Report Fourth Quarter & Full Year 2025 Financial Results and Hold Conference Call on February 10, 2026, Expects Q4 Revenue Between $103.6M-$103.8M
January 7, 2026
InMode Reports Third Quarter 2025 Financial Results: Quarterly Revenue of $93.2 Million, 78% Gross Margins
November 4, 2025
InMode Appoints Michael Dennison as President of North America
November 2, 2025
InMode to Participate in Upcoming Investor Conferences
October 29, 2025
InMode to Report Third Quarter 2025 Financial Results and Hold Conference Call on November 5, Expects Q3 Revenue Between $92.5M-$93.0M, Reiterates FY 2025 Guidance Between $365M-$375M
October 8, 2025
InMode to Present at Baird 2025 Global Healthcare Conference
September 1, 2025
InMode Reports Second Quarter 2025 Financial Results: Quarterly Revenue of $95.6 Million, 80% Gross Margins
July 29, 2025
InMode to Report Second Quarter 2025 Financial Results and Hold Conference Call on July 30, Expects Q2 Revenue Between $95.4M-$95.5M, Decreases Full Year 2025 Revenue Guidance to be Between $365M-$375M
July 9, 2025
InMode Response Letter to DOMA by Moshe Mizrahy, CEO, Dated May 28, 2025
May 27, 2025
InMode Announces Health Canada Certification of the IgniteRF Platform with the New QuantumRF Technology
May 20, 2025
InMode to Present at Upcoming Investor Conferences and Events
May 6, 2025
InMode Granted Injunction Against Counterfeit Sales of Morpheus8 Radio Frequency Microneedling Devices and Needle Cartridges
May 5, 2025
InMode Reports First Quarter 2025 Financial Results; Quarterly Revenue of $77.9 Million Represents 3% Year-Over-Year Decrease
April 27, 2025
InMode to Report First Quarter 2025 Financial Results and Hold Conference Call on April 28, 2025, Expects Q1 Revenue Between $77.2M-$77.5M, Reiterates FY 2025 Revenue Guidance Between $395M-$405M
April 13, 2025
InMode to Present at the 24th Annual Needham Virtual Healthcare Conference
March 25, 2025
InMode Responds to Doma Perpetual's Letters
March 5, 2025
InMode to Present at Upcoming Investor Conferences
March 2, 2025
InMode Reports Fourth Quarter and Full Year 2024 Financial Results; Board of Directors Has Approved a New Share Repurchase Program
February 3, 2025
InMode to Participate in the BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference
February 2, 2025
InMode to Report Fourth Quarter & Full Year 2024 and Hold Conference Call on February 4, 2025, Earlier than Originally Announced
January 15, 2025
InMode to Report Fourth Quarter & Full Year 2024 Financial Results and Hold Conference Call on February 6, 2025, Expects Q4 Revenue Between $97.0M-$97.5M
January 7, 2025
InMode Reports Third Quarter 2024 Financial Results; Quarterly GAAP Revenue of $130.2 Million (which consists of $98.3 million of net sales in Q3 and $31.9 million of pre-orders from the first half of 2024)
October 29, 2024
InMode Granted Preliminary Injunction Against Online Sellers Prohibiting Counterfeit Sales of Morpheus8 Radiofrequency Devices and Cartridge Accessories
October 23, 2024
InMode to Report Third Quarter 2024 Financial Results and Hold Conference Call on October 30, 2024
October 9, 2024
InMode Announces Departures of President of North America, Chief Medical Officer and VP of Sales USA as Part of a Global Reorganization Strategy
September 30, 2024
InMode Announces Share Repurchase Program of Up to 7.68 Million Shares
September 9, 2024
InMode to Present at 2024 Baird Global Healthcare Conference
September 3, 2024
InMode Reports Second Quarter 2024 Financial Results; Quarterly Revenue of $86.4M Represents 36.5% Year-Over-Year Decrease; Pro Forma Revenue (including new platform pre-orders not yet delivered) of $102.6M
July 31, 2024
InMode Introduces IgniteRF The Complete Minimally Invasive Soft Tissue Contraction Platform
July 30, 2024
Morpheus8 Secures First and Only FDA Clearance for Soft Tissue Contraction for Fractional Radiofrequency Microneedling
July 16, 2024
InMode to Report Second Quarter 2024 Financial Results and Hold Conference Call on Aug. 1, 2024
July 10, 2024
InMode to Present at Jefferies Healthcare Conference
May 15, 2024
InMode Announces P1 Offshore Racing Partnership with Female Driver Victoria Rand
May 7, 2024
InMode Reports First Quarter 2024 Financial Results; Quarterly Revenue of $80.3M Represents 24% Year-Over-Year Decrease; Pro Forma Revenue (including new platform pre-orders not yet available) of $96M;
May 1, 2024